Avidity Biosci Rg

Inc. harnesses antibody‑oligonucleotide conjugate (AOC) technology to deliver RNA therapeutics for rare neuromuscular and cardiomyopathy disorders. Its Phase‑3 myotonic dystrophy lead and expanding pipeline target high‑growth personalized‑medicine markets.

Headquarters: United States (USA)

Avidity Biosci Rg Logo
Company Profile
  • Employees: 391
  • HQ: San Diego
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
RNA Avidity Biosci Rg
Cap: 10.9B
EQUITY NMS USD US05370A1088 Active
📈
Home Login